
Castle Biosciences CSTL
$ 39.4
-1.73%
Quarterly report 2025-Q3
added 11-03-2025
Castle Biosciences Historical Prices 2011-2025 | CSTL
Annual Historical Prices Castle Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.5 | 24.5 | 25.4 | 42.9 | 67.2 | 34.4 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 67.2 | 24.5 | 36.6 |
Historical Prices of other stocks in the Diagnostics research industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
8.85 | $ 19.37 | 0.41 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
8.43 | $ 21.18 | -0.17 % | $ 228 M | ||
|
Co-Diagnostics
CODX
|
1.19 | $ 0.24 | -2.41 % | $ 7.04 M | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
208 | $ 230.32 | -0.31 % | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
1.53 | $ 10.04 | - | $ 285 M | ||
|
BioNano Genomics
BNGO
|
2.79 | $ 1.52 | - | $ 1.93 M | ||
|
Exact Sciences Corporation
EXAS
|
50.3 | $ 101.57 | 0.03 % | $ 18.8 B | ||
|
DexCom
DXCM
|
126 | $ 67.57 | 0.22 % | $ 26.1 B | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
15.4 | $ 26.72 | -1.07 % | $ 808 M | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
9.69 | $ 19.48 | -1.27 % | $ 1.05 B | ||
|
Celcuity
CELC
|
10.1 | $ 102.25 | -0.35 % | $ 4.03 B | ||
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
2.22 | $ 3.2 | -6.43 % | $ 102 K | ||
|
Myriad Genetics
MYGN
|
10.7 | $ 6.48 | -1.07 % | $ 587 M | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
197 | $ 226.92 | 0.43 % | $ 41.1 B | ||
|
ENDRA Life Sciences
NDRA
|
4.1 | $ 5.08 | -0.39 % | $ 2.73 M | ||
|
Neogen Corporation
NEOG
|
4.7 | $ 7.13 | -0.14 % | $ 1.55 B | ||
|
Guardant Health
GH
|
47.6 | $ 102.98 | 0.59 % | $ 12.6 B | ||
|
National Research Corporation
NRC
|
41.1 | $ 18.66 | 0.05 % | $ 458 M | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
Personalis
PSNL
|
4.28 | $ 8.14 | -3.21 % | $ 482 M | ||
|
Quidel Corporation
QDEL
|
103 | $ 29.3 | 1.35 % | $ 1.23 B | ||
|
QIAGEN N.V.
QGEN
|
38.3 | $ 45.37 | -0.24 % | $ 10.1 B | ||
|
Illumina
ILMN
|
103 | $ 134.95 | -0.27 % | $ 21.5 B | ||
|
RadNet
RDNT
|
50.4 | $ 73.15 | 0.29 % | $ 5.34 B | ||
|
Charles River Laboratories International
CRL
|
166 | $ 203.66 | 0.25 % | $ 10.5 B | ||
|
Soleno Therapeutics
SLNO
|
48.7 | $ 47.65 | -3.03 % | $ 1.91 B | ||
|
Quest Diagnostics Incorporated
DGX
|
172 | $ 175.94 | 0.03 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
0.71 | $ 6.82 | - | $ 884 M | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
252 | $ 253.89 | -0.22 % | $ 21.3 B | ||
|
ICON Public Limited Company
ICLR
|
201 | $ 182.84 | -0.46 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
457 | $ 688.48 | 0.04 % | $ 56.8 B | ||
|
Lantheus Holdings
LNTH
|
93.4 | $ 66.71 | 0.04 % | $ 4.62 B | ||
|
Mettler-Toledo International
MTD
|
1.41 K | $ 1 420.1 | 0.21 % | $ 30.1 B |